ImmunityBio (IBRX) Shareholder's Equity (2013 - 2026)

ImmunityBio (IBRX) Shareholder's Equity (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 ImmunityBio 7.55 Bn 7.17 Bn 43.97 Mn -869.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -869.13 Mn
Dec 31, 2025 -500.47 Mn
Sep 30, 2025 -523.41 Mn
Jun 30, 2025 -569.82 Mn
Mar 31, 2025 -590.48 Mn
Dec 31, 2024 -488.13 Mn
Sep 30, 2024 -744.16 Mn
Jun 30, 2024 -697.38 Mn
Mar 31, 2024 -690.98 Mn
Dec 31, 2023 -585.94 Mn
Sep 30, 2023 -410.65 Mn
Jun 30, 2023 -645.18 Mn
Mar 31, 2023 -531.72 Mn
Dec 31, 2022 -449.82 Mn
Sep 30, 2022 -429.08 Mn
Jun 30, 2022 -421.97 Mn
Mar 31, 2022 -337.56 Mn
Dec 31, 2021 -243.91 Mn
Sep 30, 2021 -189.94 Mn
Jun 30, 2021 -158.59 Mn